Adenosine is a cardiac drug that is used for the treatment of paroxysmal supraventricular tachycardia (PSVT) including that associated with accessory bypass tracts (Wolff-Parkinson-White syndrome).
Adverse reactions or quality problems experienced with the use of this Product may be reported to the FDA’s MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
Related Information
Labeling and Regulatory History from Drugs@FDA
-
Content current as of:
12/12/2014
